Isogenica Limited Announces New Collaboration with NovaBiotics Ltd

Published: Oct 05, 2010

CAMBRIDGE, England--(BUSINESS WIRE)--Isogenica Ltd, today announced that it has entered into a collaboration agreement with NovaBiotics, a leading clinical-stage biotechnology company to fast-track the development of NovaBiotic’s platform peptide anti-infective technology.

Back to news